Research | OneLook Acronym Finder |
Serial Number | 87110093 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Gretchen R. Stroud |
Attorney Docket Number | 06530 |
Law Office Assigned | N20 |
Employee Name | FRIEDMAN, LESLEE ANN |
2016-07-20 | Application Filed |
2017-05-02 | Published for Opposition |
2019-11-12 | Location: INTENT TO USE SECTION |
2019-11-15 | Status: Live/Pending |
2019-11-16 | Transaction Date |
Owner: | Gilead Sciences Ireland UC |
Entity Statement | Unlimited Company |
Address | IDA Business and Technology Park Carrigtohill, Co. IE |
Legal Entity Type | |
Legal Entity State | IE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis |
GS0051 | Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2016-07-23 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-07-25 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2016-08-30 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2016-08-30 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2016-08-30 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-08-30 | 6 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-02-23 | 7 TROA I:Incoming Correspondence |
ASSIGNED TO LIE | 2017-03-10 | 8 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-03-15 | 9 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-03-15 | 10 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-03-18 | 11 CNSA P: |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2017-03-27 | 12 PREV O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-04-12 | 13 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2017-05-02 | 14 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-05-02 | 15 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-06-27 | 16 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2017-10-19 | 17 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2017-10-19 | 18 EXT1 S: |
EXTENSION 1 GRANTED | 2017-10-19 | 19 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-10-21 | 20 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2018-04-27 | 21 EEXT I:Incoming Correspondence |
EXTENSION 2 FILED | 2018-04-27 | 22 EXT2 S: |
EXTENSION 2 GRANTED | 2018-04-27 | 23 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-05-01 | 24 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2018-11-02 | 25 EEXT I:Incoming Correspondence |
EXTENSION 3 FILED | 2018-11-02 | 26 EXT3 S: |
EXTENSION 3 GRANTED | 2018-11-02 | 27 EX3G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-11-06 | 28 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-04-29 | 29 EEXT I:Incoming Correspondence |
EXTENSION 4 FILED | 2019-04-29 | 30 EXT4 S: |
EXTENSION 4 GRANTED | 2019-04-29 | 31 EX4G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-05-01 | 32 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-11-07 | 33 EEXT I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-11-12 | 34 AITU A:Allowance for Publication |
EXTENSION 5 FILED | 2019-11-07 | 35 EXT5 S: |
EXTENSION 5 GRANTED | 2019-11-15 | 36 EX5G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-11-16 | 37 EXRA E:E-Mail |
TEAS DELETE 1(B) BASIS RECEIVED | 2020-05-04 | 38 D1BR I:Incoming Correspondence |
NOTICE OF ALLOWANCE CANCELLED | 2020-05-04 | 39 IUCN S: |
1(B) BASIS DELETED; PROCEED TO REGISTRATION | 2020-05-22 | 40 DP1B I:Incoming Correspondence |
REGISTERED-PRINCIPAL REGISTER | 2020-06-30 | 41 R.PR A:Allowance for Publication |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-10-11 | 42 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-10-11 | 43 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-10-11 | 44 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-10-11 | 45 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-10-11 | 46 CHAN I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.